Natural rubber latex allergy in children: Clinical and immunological effects of 3-years sublingual immunotherapy

R. Bernardini, S. Pecora, M. Milani, S. E. Burastero

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Background: We previously demonstrated that one year of sublingual immunotherapy (SLIT) with natural rubber latex (NRL) was safe and efficacious in paediatric patients with NRL allergy. Research Design and Methods: We studied 12 NRL-allergic children (age 4-15), previously assigned to the treated arm of a double-blind placebo controlled study, who received a commercial latex SLIT for three years. Adverse reactions were monitored. The primary end-point was the NRL glove-use test. As secondary end-points, skin prick test with NRL and NRL serum specific IgE were used. Main outcomes measures: No SLIT-related side effects were observed. A significant reduction of the glove-use score was observed after one-year treatment (5.1 ± 4.2 vs. 14.8 ± 5.7, p=0.0031). This parameter was further reduced in the second year since SLIT start (2.0 ±2.7, p=000007). After 3 years of SLIT all patients had a negative glove-use test (p2) were significantly reduced after 2 (5.3 ± 1.8 mm2) and 3 years (4.0 ± 1.8 mm2) of SLIT (p=0.039 and 0.027, respectively). Baseline values of serum specific IgE (23 ± 34 KU/l) were significantly reduced after 3 years since SLIT start (6.4 ± 5.0, p=0.0371). Conclusions: Three years of latex SLIT is safe and consolidates the efficacy previously observed after one year of treatment in paediatric patients.

Original languageEnglish
Pages (from-to)142-147
Number of pages6
JournalEuropean Annals of Allergy and Clinical Immunology
Volume40
Issue number4
Publication statusPublished - Dec 2008

Fingerprint

Sublingual Immunotherapy
Latex Hypersensitivity
Rubber
Latex
Immunoglobulin E
Pediatrics
Skin Tests
Serum
Research Design
Placebos
Outcome Assessment (Health Care)

Keywords

  • Allergy
  • Children
  • Latex
  • Sublingual immunotherapy

ASJC Scopus subject areas

  • Immunology and Allergy

Cite this

Natural rubber latex allergy in children : Clinical and immunological effects of 3-years sublingual immunotherapy. / Bernardini, R.; Pecora, S.; Milani, M.; Burastero, S. E.

In: European Annals of Allergy and Clinical Immunology, Vol. 40, No. 4, 12.2008, p. 142-147.

Research output: Contribution to journalArticle

@article{3c142872a53542feb1f62e75f77f29f0,
title = "Natural rubber latex allergy in children: Clinical and immunological effects of 3-years sublingual immunotherapy",
abstract = "Background: We previously demonstrated that one year of sublingual immunotherapy (SLIT) with natural rubber latex (NRL) was safe and efficacious in paediatric patients with NRL allergy. Research Design and Methods: We studied 12 NRL-allergic children (age 4-15), previously assigned to the treated arm of a double-blind placebo controlled study, who received a commercial latex SLIT for three years. Adverse reactions were monitored. The primary end-point was the NRL glove-use test. As secondary end-points, skin prick test with NRL and NRL serum specific IgE were used. Main outcomes measures: No SLIT-related side effects were observed. A significant reduction of the glove-use score was observed after one-year treatment (5.1 ± 4.2 vs. 14.8 ± 5.7, p=0.0031). This parameter was further reduced in the second year since SLIT start (2.0 ±2.7, p=000007). After 3 years of SLIT all patients had a negative glove-use test (p2) were significantly reduced after 2 (5.3 ± 1.8 mm2) and 3 years (4.0 ± 1.8 mm2) of SLIT (p=0.039 and 0.027, respectively). Baseline values of serum specific IgE (23 ± 34 KU/l) were significantly reduced after 3 years since SLIT start (6.4 ± 5.0, p=0.0371). Conclusions: Three years of latex SLIT is safe and consolidates the efficacy previously observed after one year of treatment in paediatric patients.",
keywords = "Allergy, Children, Latex, Sublingual immunotherapy",
author = "R. Bernardini and S. Pecora and M. Milani and Burastero, {S. E.}",
year = "2008",
month = "12",
language = "English",
volume = "40",
pages = "142--147",
journal = "Allergie et Immunologie",
issn = "0397-9148",
publisher = "Mattioli 1885 S.p.A.",
number = "4",

}

TY - JOUR

T1 - Natural rubber latex allergy in children

T2 - Clinical and immunological effects of 3-years sublingual immunotherapy

AU - Bernardini, R.

AU - Pecora, S.

AU - Milani, M.

AU - Burastero, S. E.

PY - 2008/12

Y1 - 2008/12

N2 - Background: We previously demonstrated that one year of sublingual immunotherapy (SLIT) with natural rubber latex (NRL) was safe and efficacious in paediatric patients with NRL allergy. Research Design and Methods: We studied 12 NRL-allergic children (age 4-15), previously assigned to the treated arm of a double-blind placebo controlled study, who received a commercial latex SLIT for three years. Adverse reactions were monitored. The primary end-point was the NRL glove-use test. As secondary end-points, skin prick test with NRL and NRL serum specific IgE were used. Main outcomes measures: No SLIT-related side effects were observed. A significant reduction of the glove-use score was observed after one-year treatment (5.1 ± 4.2 vs. 14.8 ± 5.7, p=0.0031). This parameter was further reduced in the second year since SLIT start (2.0 ±2.7, p=000007). After 3 years of SLIT all patients had a negative glove-use test (p2) were significantly reduced after 2 (5.3 ± 1.8 mm2) and 3 years (4.0 ± 1.8 mm2) of SLIT (p=0.039 and 0.027, respectively). Baseline values of serum specific IgE (23 ± 34 KU/l) were significantly reduced after 3 years since SLIT start (6.4 ± 5.0, p=0.0371). Conclusions: Three years of latex SLIT is safe and consolidates the efficacy previously observed after one year of treatment in paediatric patients.

AB - Background: We previously demonstrated that one year of sublingual immunotherapy (SLIT) with natural rubber latex (NRL) was safe and efficacious in paediatric patients with NRL allergy. Research Design and Methods: We studied 12 NRL-allergic children (age 4-15), previously assigned to the treated arm of a double-blind placebo controlled study, who received a commercial latex SLIT for three years. Adverse reactions were monitored. The primary end-point was the NRL glove-use test. As secondary end-points, skin prick test with NRL and NRL serum specific IgE were used. Main outcomes measures: No SLIT-related side effects were observed. A significant reduction of the glove-use score was observed after one-year treatment (5.1 ± 4.2 vs. 14.8 ± 5.7, p=0.0031). This parameter was further reduced in the second year since SLIT start (2.0 ±2.7, p=000007). After 3 years of SLIT all patients had a negative glove-use test (p2) were significantly reduced after 2 (5.3 ± 1.8 mm2) and 3 years (4.0 ± 1.8 mm2) of SLIT (p=0.039 and 0.027, respectively). Baseline values of serum specific IgE (23 ± 34 KU/l) were significantly reduced after 3 years since SLIT start (6.4 ± 5.0, p=0.0371). Conclusions: Three years of latex SLIT is safe and consolidates the efficacy previously observed after one year of treatment in paediatric patients.

KW - Allergy

KW - Children

KW - Latex

KW - Sublingual immunotherapy

UR - http://www.scopus.com/inward/record.url?scp=59749097998&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=59749097998&partnerID=8YFLogxK

M3 - Article

C2 - 19227650

AN - SCOPUS:59749097998

VL - 40

SP - 142

EP - 147

JO - Allergie et Immunologie

JF - Allergie et Immunologie

SN - 0397-9148

IS - 4

ER -